TGA gives CSL local vaccine manufacturing approval

The Therapeutic Goods Administration on Sunday approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia by CSL’s Seqirus vaccine division. This follows on from the 16 February 2021 approval by TGA of the overseas-manufactured AstraZeneca vaccine. The delay in both approvals is part of criticism of the federal government’s vaccine rollout – see separate…

Think strategically about operations and supply chains- by Mohsen Varsei

Mohsen Varsei takes a look at the parlous state of Australian manufacturing. He argues the answer is to refocus on operations and supply chain excellence. This sets new business horizons and becomes the manufacturing firm’s advantage. The government recently acknowledged that ‘manufacturing in Australia has stagnated. Not enough manufacturers are scaling-up’. Its ‘vision is for…